NEW YORK (GenomeWeb News) – PathoGenetix today said it has signed a collaborative agreement with the US Food and Drug Administration to evaluate the company's technology for use in foodborne illness outbreak investigation and response.
Bacterial typing systems developer PathoGenetix has hired Paul Krassnoff to be director of manufacturing. In this post, he will develop production and quality assurance systems for the firm's Genome Sequence Scanning System.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – PathoGenetix today announced it has raised $7.5 million in a second closing of a Series B financing round, bringing the total raised in the round to $11.5 million.
The company, formerly called US Genomics, will use the funding to complete development of its system for identifying pathogens in complex biological samples, which is scheduled for commercial release in 2012.